References

1. Centers for Disease Control and Prevention (2024). Osteoarthritis. [online] Arthritis. Available at: https://www.cdc.gov/arthritis/osteoarthritis/index.html.

2. Osteoarthritis Research Society International (2025). Patients | Osteoarthritis Research Society International (OARSI). [online] oarsi.org. Available at: https://oarsi.org/education/patients.

3. Allen, K., Thoma, L. and Golightly, Y. (2021). Epidemiology of osteoarthritis. Osteoarthritis and Cartilage, [online] 30(2), pp.184–195. doi:https://doi.org/10.1016/j.joca.2021.04.020.

4. Zhang, S., Wang, D., Zhao, J., Zhao, H., Xie, P., Zheng, L., Sheng, P., Yuan, J., Xia, B., Wei, F. and Zhang, Z. (2024). Metabolic syndrome increases osteoarthritis risk: findings from the UK Biobank prospective cohort study. BMC Public Health, 24(1). doi:https://doi.org/10.1186/s12889-024-17682-z.

5. Yucesoy, B., Charles, L.E., Baker, B. and Burchfiel, C.M. (2015). Occupational and genetic risk factors for osteoarthritis: A review. Work, [online] 50(2), pp.261–273. doi:https://doi.org/10.3233/wor-131739.

6. NHS (2023). Osteoarthritis. [online] NHS. Available at: https://www.nhs.uk/conditions/osteoarthritis/.

7. Braun, H.J. and Gold, G.E. (2012). Diagnosis of osteoarthritis: Imaging. Bone, [online] 51(2), pp.278–288. doi:https://doi.org/10.1016/j.bone.2011.11.019.

8. Lieberthal, J., Sambamurthy, N. and Scanzello, C.R. (2015). Inflammation in Joint Injury and Post-Traumatic Osteoarthritis. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society, [online] 23(11), pp.1825–1834. doi:https://doi.org/10.1016/j.joca.2015.08.015.

9. Arthritis Foundation (2024). Osteoarthritis. [online] Arthritis Foundation. Available at: https://www.arthritis.org/diseases/osteoarthritis.

10. Pi, S.-W., Lee, B.-D., Lee, M.S. and Lee, H.J. (2023). Ensemble deep-learning networks for automated osteoarthritis grading in knee X-ray images. Scientific Reports, [online] 13(1), p.22887. doi:https://doi.org/10.1038/s41598-023-50210-4.

11. Salva, J.E. and Merrill, A.E. (2016). Signaling networks in joint development. Developmental Dynamics, 246(4), pp.262–274. doi:https://doi.org/10.1002/dvdy.24472.

12. Tamer, T.M. (2013). Hyaluronan and synovial joint: function, distribution and healing. Interdisciplinary Toxicology, [online] 6(3), pp.111–125. doi:https://doi.org/10.2478/intox-2013-0019.

13. Cleveland Clinic (2021). Tendon: Function, Anatomy & Common Injuries. [online] Cleveland Clinic. Available at: https://my.clevelandclinic.org/health/body/21738-tendon.

14. Loiacono, C., Palermi, S., Massa, B., Belviso, I., Romano, V., Gregorio, A.D., Sirico, F. and Sacco, A.M. (2019). Tendinopathy: Pathophysiology, Therapeutic Options, and Role of Nutraceutics. A Narrative Literature Review. Medicina, [online] 55(8), p.447. doi:https://doi.org/10.3390/medicina55080447.

15. Mayo Clinic (2025). Tendinopathy - Symptoms and causes. [online] Mayo Clinic. Available at: https://www.mayoclinic.org/diseases-conditions/tendinopathy/symptoms-causes/syc-20580660.

16. Canada, (2024). Tendon Disorders. [online] Ccohs.ca. Available at: https://www.ccohs.ca/oshanswers/diseases/tendon_disorders.html#section-7-hdr.

17. Conforti, M. (2020). Combination of laser needling and hyaluronic acid infiltration treatments for rotator cuff calcific tendinopathies - Gazzetta Medica Italiana - Archivioper le Scienze Mediche 2020 December;179(12):665-74. [online] Minervamedica.it. Available at: https://www.minervamedica.it/en/journals/gazzetta-medica-italiana/article.php?cod=R22Y2020N12A0665.

18. Abate, M., Schiavone, C. and Salini, V. (2014). The Use of Hyaluronic Acid after Tendon Surgery and in Tendinopathies. BioMed Research International, 2014, pp.1–6. doi:https://doi.org/10.1155/2014/783632.

19. Cleveland Clinic (2022). Hyaluronic Acid: What It Is, Benefits, How To Use & Side Effects. [online] Cleveland Clinic. Available at: https://my.clevelandclinic.org/health/articles/22915-hyaluronic-acid.

20. Tenti, S., Pascarelli, N.A., Giannotti, S., Galeazzi, M., Giordano, N. and Fioravanti, A. (2017). Can hybrid hyaluronic acid represent a valid approach to treat rizoarthrosis? A retrospective comparative study. BMC Musculoskeletal Disorders, 18(1). doi:https://doi.org/10.1186/s12891-017-1809-5.

21. Sallì, M., Grasso, G. and Foti, C. (2024). Comparison of Two Hyaluronic Acid Preparations for the Treatment of Rizoarthrosis. Journal of Physical Medicine Rehabilitation Studies & Reports, [online] pp.1–6. doi:https://doi.org/10.47363/jpmrs/2024(6)199.

22. Marcin Domżalski and Migliore, A. (2022). A Review of the Clinical Effectiveness and Safety of Hybrid Cooperative Complexes in Intra-articular Viscosupplementation. Rheumatology and Therapy, 9(4), pp.957–974. doi:https://doi.org/10.1007/s40744-022-00450-z.

23. Abate, M. and Salini, V. (2017). Efficacy and safety study on a new compound associating low and high molecular weight hyaluronic acid in the treatment of hip osteoarthritis. International Journal of Immunopathology and Pharmacology, 30(1), pp.89–93. doi:https://doi.org/10.1177/0394632016689275.

24. Schiraldi, C. (2016). Hyaluronan viscosupplementation: state of the art and insight into the novel cooperative hybrid complexes based on high and low molecular weight HA of potential interest in osteoarthritis treatment. Clinical Cases in Mineral and Bone Metabolism. doi:https://doi.org/10.11138/ccmbm/2016.13.1.036.

25. Migliore, A., Blicharski, T., Plebanski, R., Zegota, Z., Gyula, G., Rannou, F. and Reginster, J.-Y. (2021). Knee Osteoarthritis Pain Management with an Innovative High and Low Molecular Weight Hyaluronic Acid Formulation (HA-HL): A Randomized Clinical Trial. Rheumatology and Therapy, [online] 8(4), pp.1617–1636. doi:https://doi.org/10.1007/s40744-021-00363-3.

26. Arthritis Foundation (n.d.). Vitamin and Mineral Guide for Arthritis | Arthritis Foundation. [online] www.arthritis.org. Available at: https://www.arthritis.org/health-wellness/treatment/complementary-therapies/supplements-and-vitamins/vitamin-and-mineral-guide-for-arthritis.

27. Carhan, E. (2024). How Foods Affect Your Arthritis | Oak Tree Mobility. [online] Oaktreemobility.co.uk. Available at: https://oaktreemobility.co.uk/help-and-advice/health-and-wellbeing/how-foods-affect-your-arthritis [Accessed 9 Jul. 2025].

28. National Institutes of Health (2022). Office of Dietary Supplements - Omega-3 Fatty Acids. [online] Nih.gov. Available at: https://ods.od.nih.gov/factsheets/Omega3FattyAcids-Consumer/.

29. NHS (2022). Keep bones healthy over 65. [online] nhs.uk. Available at: https://www.nhs.uk/live-well/bone-health/keep-your-bones-strong-over-65/.

30. Tang, S., Zhang, C., Oo, W.M., Fu, K., Risberg, M.A., Bierma-Zeinstra, S.M., Neogi, T., Atukorala, I., Malfait, A.-M., Ding, C. and Hunter, D.J. (2025). Osteoarthritis. Nature reviews. Disease primers, [online] 11(1), p.10. doi:https://doi.org/10.1038/s41572-025-00594-6.

31. GBD 2021 Osteoarthritis Collaborators (2023). Global, regional, and National Burden of osteoarthritis, 1990–2020 and Projections to 2050: a Systematic Analysis for the Global Burden of Disease Study 2021. The Lancet Rheumatology, [online] 5(9), pp.e508–e522. doi:https://doi.org/10.1016/s2665-9913(23)00163-7.

32. Versus Arthritis (2023). The State of Musculoskeletal Health. [online] Versus Arthritis. Available at: https://versusarthritis.org/about-arthritis/data-and-statistics/the-state-of-musculoskeletal-health/.

33. Fu, K., Robbins, S.R. and McDougall, J.J. (2017). Osteoarthritis: the genesis of pain. Rheumatology, [online] 57(suppl_4), pp.iv43–iv50. doi:https://doi.org/10.1093/rheumatology/kex419.

34. Moreland, L.W. (2003). Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Research & Therapy, 5(2), p.54. doi:https://doi.org/10.1186/ar623.

35. Bannuru, R.R., Kent, D.M. and McAlindon, T.E. (2015). Pharmacologic Interventions for Knee Osteoarthritis. Annals of Internal Medicine, 162(9), p.672. doi:https://doi.org/10.7326/l15-5090-2.

36. Chakrabarti, S. (2019). Joint lubricating fluid plays key role in osteoarthritic pain, study finds. [online] University of Cambridge. Available at: https://www.cam.ac.uk/research/news/joint-lubricating-fluid-plays-key-role-in-osteoarthritic-pain-study-finds.

37. Scott, A., Backman, L.J. and Speed, C. (2015). Tendinopathy: Update on Pathophysiology. Journal of Orthopaedic & Sports Physical Therapy, [online] 45(11), pp.833–841. doi:https://doi.org/10.2519/jospt.2015.5884.

38. Kusel, K. and Knipe, H. (2019). Tendon rupture. Radiopaedia.org. [online] doi:https://doi.org/10.53347/rid-69904.

39. Temple-Wong, M.M., Ren, S., Quach, P., Hansen, B.C., Chen, A.C., Hasegawa, A., D’Lima, D.D., Koziol, J., Masuda, K., Lotz, M.K. and Sah, R.L. (2016). Hyaluronan concentration and size distribution in human knee synovial fluid: variations with age and cartilage degeneration. Arthritis Research & Therapy, 18(1). doi:https://doi.org/10.1186/s13075-016-0922-4.

40. Thierry Conrozier, Mathieu, P., Vignon, E., Piperno, M. and Rinaudo, M. (2012). Differences in the osteoarthritic synovial fluid composition and rheology between patients with or without flare: a pilot study. HAL (Le Centre pour la Communication ScientifiqueDirecte), 30(5), pp.729–34.

41. Lee, M. (2015). Tendon Pathophysiology. [online] Physiopedia. Available at: https://www.physio-pedia.com/Tendon_Pathophysiology.

42. Hasan, S.A., Othman, A.A., Shagdar, Y.K., Khan, A.A., Sulaimani, A.B., Alsinan, H.A., Almenhali, A.A., Al Luhayb, W.A., Alrashidi, A.A., Alghareeb, M.A. and Aldakheel, R.S. (2021). Epidemiology, etiology, and pathogenesis of tendinopathy among athletes. International Journal Of Community Medicine And Public Health, 9(1), p.437. doi:https://doi.org/10.18203/2394-6040.ijcmph20215022.

43. Al Makhzoomi, A.K., Kirk, T.B., Dye, D.E. and Allison, G.T. (2021). Contribution of glycosaminoglycans to the structural and mechanical properties of tendons – A multiscale study. Journal of Biomechanics, [online] 128, p.110796. doi:https://doi.org/10.1016/j.jbiomech.2021.110796.

44. Menezes, R., Vincent, R., Osorno, L., Hu, P. and Arinzeh, T.L. (2022). Biomaterials and Tissue Engineering Approaches using Glycosaminoglycans for Tissue Repair: Lessons Learned from the Native Extracellular Matrix. Acta Biomaterialia. doi:https://doi.org/10.1016/j.actbio.2022.09.064.

45. Max F.R. Merkel, Svensson, R.B., Jakobsen, J.R., Mackey, A.L., Schjerling, P., Herzog, R.B., S. Peter Magnusson, Lars Konradsen, Krogsgaard, M.R., Kjær, M. and Johannsen, F.E. (2024). Widespread Vascularization and Correlation of Glycosaminoglycan Accumulation to Tendon Pain in Human Plantar Fascia Tendinopathy. The American journal of sports medicine. doi:https://doi.org/10.1177/03635465241246262.

46. Casale, J. and Crane, J.S. (2019). Biochemistry, Glycosaminoglycans. [online] Nih.gov. Available at: https://www.ncbi.nlm.nih.gov/books/NBK544295/.

47. Goutam Brahmachari (2019). Discovery and Development of Anti-inflammatory Agents from Natural Products. Elsevier.

48. Zhu, Z., Wang, Y.-M., Yang, J. and Luo, X.-S. (2017). Hyaluronic acid: a versatile biomaterial in tissue engineering. Plastic and Aesthetic Research, 4(12), p.219. doi:https://doi.org/10.20517/2347-9264.2017.71.

49. Farmah, B. (2023). The History and Evolution Of Hyaluronic Acid. [online] Dr Aesthetica. Available at: https://draesthetica.co.uk/ask-aesthetica/the-history-and-evolution-of-hyaluronic-acid/.

50. Couto, M.R., Lúcia, J. and Rodrigues, L.R. (2022). Heterologous production of chondroitin. Biotechnology Reports, 33, pp.e00710–e00710. doi:https://doi.org/10.1016/j.btre.2022.e00710.

51. Cowman, M.K., Schmidt, T.A., Raghavan, P. and Stecco, A. (2015). Viscoelastic Properties of Hyaluronan in Physiological Conditions. F1000Research. [online] doi:https://doi.org/10.12688/f1000research.6885.1.

52. Golovach, I., Rekalov, D., Akimov, O.Y., Kostenko, H., Kostenko, V., Mishchenko, A., Solovyova, N. and Kostenko, V. (2023). Molecular mechanisms and potential applications of chondroitin sulphate in managing post-traumatic osteoarthritis. Rheumatology, 61(5), pp.395–407. doi:https://doi.org/10.5114/reum/172211.

53. Cai, Z., Zhang, H., Wei, Y., Wu, M. and Fu, A. (2019). Shear-thinning hyaluronan-based fluid hydrogels to modulate viscoelastic properties of osteoarthritis synovial fluids. Biomaterials Science, 7(8), pp.3143–3157. doi:https://doi.org/10.1039/c9bm00298g.

54. Migliore, A. (2015). Effectiveness and utility of hyaluronic acid in osteoarthritis. Clinical Cases in Mineral and Bone Metabolism, [online] 12(1). doi:https://doi.org/10.11138/ccmbm/2015.12.1.031.

55. Jerosch, J. (2011). Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids. International Journal of Rheumatology, 2011(1), pp.1–17. doi:https://doi.org/10.1155/2011/969012.

56. Taşkesen, A., Ataoğlu, B., Özer, M., Demirkale, İ. and Turanli, S. (2015). Glucosamine-chondroitin sulphate accelerates tendon-to-bone healing in rabbits. Eklem hastaliklari vecerrahisi = Joint diseases & related surgery, [online] 26(2), pp.77–83. doi:https://doi.org/10.5606/ehc.2015.17.

57. Sinovial IFU, Proprietary information of IBSA Group.

58. Scrima, M., Merola, F., Vito, N., Pacchioni, D., Vecchi, G., Melito, C., Iorio, A., Giori, A.M. and Ferravante, A. (2022). Elucidations on the Performance and Reversibility of Treatment with Hyaluronic Acid Based Dermal Fillers: In vivo and in vitro Approaches. Clinical, Cosmetic and Investigational Dermatology, [online] 15, pp.2629–2640. doi:https://doi.org/10.2147/CCID.S383354.

59. Arthritis Foundation (n.d.). Corticosteroids | Arthritis Foundation. [online] www.arthritis.org. Available at: https://www.arthritis.org/drug-guide/corticosteroids/corticosteroids.

60. Australian Orthopaedic Association (2022). Knee osteoarthritis. [online] Aoa.org.au. Available at: https://aoa.org.au/for-patients/patient-information/knee-osteoarthritis.

61. Bannuru, R.R., Vaysbrot, E.E., Sullivan, M.C. and McAlindon, T.E. (2014). Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 43(5), pp.593–599. doi:https://doi.org/10.1016/j.semarthrit.2013.10.002.

62. Chevalier, X. and Migliore, A. (2013). Safety and Tolerability of Intra-Articular Hyaluronic Acid Injection (Sinovial®) in Experimental and Clinical Practice. European Journal of Inflammation, 11(3), pp.573–580. doi:https://doi.org/10.1177/1721727x1301100301.

63. IBSA (2022). Sinovial HL Instructions for Use UK.

64. Maheu, E., Rannou, F. and Reginster, J.-Y. (2016). Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Seminars in Arthritis and Rheumatism, [online] 45(4), pp.S28–S33. doi:https://doi.org/10.1016/j.semarthrit.2015.11.008.

65. Overton, M., Swain, N., Falling, C., Gwynne-Jones, D., Fillingim, R. and Mani, R. (2024). Understanding the biopsychosocial knee osteoarthritis pain experience: an ecological momentary assessment. PAIN Reports, [online] 9(4), p.e1172. doi:https://doi.org/10.1097/pr9.0000000000001172.

66. Lou, Z. and Bu, F. (2025). Recent advances in osteoarthritis research: A review of treatment strategies, mechanistic insights, and acupuncture. Medicine, 104(4), pp.e41335–e41335. doi:https://doi.org/10.1097/md.0000000000041335.

67. NICE (2022). Recommendations | Osteoarthritis in over 16s: diagnosis and management | Guidance | NICE. [online] www.nice.org.uk. Available at: https://www.nice.org.uk/guidance/ng226/chapter/Recommendations.

68. Wang, X., Hunter, D.J., Jin, X. and Ding, C. (2018). The importance of synovial inflammation in osteoarthritis: current evidence from imaging assessments and clinical trials. Osteoarthritis and Cartilage, 26(2), pp.165–174. doi:https://doi.org/10.1016/j.joca.2017.11.015.

69. Government of Canada, C.C. for O.H. and S. (2020). Tendon Disorders : OSH Answers. [online] www.ccohs.ca. Available at: https://www.ccohs.ca/oshanswers/diseases/tendon_disorders.html.

70. NHS (2019). Tendonitis. [online] NHS. Available at: https://www.nhs.uk/conditions/tendonitis/.